Greenwich Wealth Management LLC Amgen Inc Transaction History

Greenwich Wealth Management LLC

$1.47 Billion
Q3 2024

A detailed history of Greenwich Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Greenwich Wealth Management LLC holds 1,210 shares of AMGN stock, worth $350,779. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,210

Previous 1,367 11.49%

Holding current value

$350,779

Previous $427,000 8.67%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $48,572 - $52,968	-157 Reduced 11.49%	1,210 $390,000
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $2,627 - $3,193	-10 Reduced 0.73%	1,367 $427,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $8,603 - $10,385	32 Added 2.38%	1,377 $392,000
Q4 2023 Feb 01, 2024	SELL	$255.7 - $288.46 $16,620 - $18,749	-65 Reduced 4.61%	1,345 $387,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $11,151 - $13,844	51 Added 3.75%	1,410 $379,000
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $677 - $825	-3 Reduced 0.22%	1,359 $328,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $23,343 - $26,327	-104 Reduced 7.09%	1,362 $307,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $1,614 - $1,797	-7 Reduced 0.48%	1,466 $357,000
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $10,524 - $11,643	-48 Reduced 3.16%	1,473 $356,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $1,988 - $2,276	-10 Reduced 0.65%	1,521 $342,000
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $147,739 - $173,095	696 Added 83.35%	1,531 $326,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $195,039 - $216,381	835 New	835 $203,000

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.

Account

Greenwich Wealth Management LLC Amgen Inc Transaction History